Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jounce Therapeutics, Inc. | Director | Common Stock | 1 | $1.85 | $1.85 | May 3, 2023 | Direct |
Jounce Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | May 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JNCE | Jounce Therapeutics, Inc. | May 3, 2023 | 11 | $0 | 4 | May 4, 2023 | Director |
JNCE | Jounce Therapeutics, Inc. | Apr 4, 2023 | 1 | -$72.6K | 4 | Apr 6, 2023 | Director |
JNCE | Jounce Therapeutics, Inc. | Jan 9, 2023 | 2 | -$50.1K | 4 | Jan 11, 2023 | CEO and President, Director |
JNCE | Jounce Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | CEO and President, Director |
JNCE | Jounce Therapeutics, Inc. | Jan 7, 2022 | 2 | -$257K | 4 | Jan 11, 2022 | CEO and President, Director |